Aditxt, Inc. (ADTX) vs Onconetix, Inc. (ONCO)
Aditxt, Inc. and Onconetix, Inc. are both Biotechnology companies. Aditxt, Inc. and Onconetix, Inc. are of similar size ($4.6M and $4.4M). Aditxt, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Onconetix, Inc. grew revenue faster over the last twelve months: −51.3% against −74.2%. Onconetix, Inc. has the higher net margin (−1,578.6% vs −372,998.6%) and the lower return on invested capital (−135.4% vs 0.00%). Across the 14 metrics below, Onconetix, Inc. leads on 9 and Aditxt, Inc. on 5.
Valuation
Profitability
| Metric | ADTX | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 20.28% | 80.38% | 65.16% |
| Operating margin | (128,143.36%) | (2,524.73%) | 0.00% |
| Net margin | (372,998.60%) | (1,578.60%) | 0.00% |
| Free cash flow margin | (129,979.72%) | (1,595.90%) | 0.00% |
| Return on equity | 549.59% | (105.23%) | (57.72%) |
| Return on assets | (236.38%) | (57.37%) | (49.22%) |
| Return on invested capital | 0.00% | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack